Literature DB >> 25592613

Virological and molecular biological evidence supporting herpes simplex virus type 1 corneal latency.

Shiro Higaki1, Masahiko Fukuda, Yoshikazu Shimomura.   

Abstract

PURPOSE: Trigeminal and other ganglia are known as sites of latent infection by herpes simplex virus type 1 (HSV-1). In ophthalmology, HSV-1 remains latent in the trigeminal ganglia, and becomes reactivated by several factors, including stress, thermal stimulation, or immunosuppression, and may lead to herpetic keratitis. The purpose of this study was to demonstrate HSV corneal latent infection using molecular biology and virology techniques.
METHODS: Six corneas obtained at penetrating keratoplasty were snap-frozen; three of them were with past history of herpetic keratitis. TaqMan Real-time PCR was used to show positive HSV DNA in the corneas. We proved negative homogenate and positive explant virologically. Using real-time RT-PCR, we showed that only latency-associated transcript (LAT) was detected and no transcriptional products of other virus genes (α, β, γ) were detected.
RESULTS: All three corneas with past history of herpetic keratitis had HSV DNA and showed negative homogenate and positive explant. LAT was detected in all three corneas. However, α, β, or γ genes were not expressed. All the results of these corneas were consistent with the conditions of corneal latency. The other three corneas without history of herpetic keratitis showed negative homogenate and negative explant. None of them had LAT.
CONCLUSION: We have shown a possibility that HSV can latently infect the cornea aside from the ganglion.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25592613     DOI: 10.1007/s10384-014-0369-6

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  22 in total

1.  Early intervention with high-dose acyclovir treatment during primary herpes simplex virus infection reduces latency and subsequent reactivation in the nervous system in vivo.

Authors:  N M Sawtell; R L Thompson; L R Stanberry; D I Bernstein
Journal:  J Infect Dis       Date:  2001-09-10       Impact factor: 5.226

2.  HSV-1 corneal latency.

Authors:  Y J Gordon; E Romanowski; T Araullo-Cruz; J L McKnight
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-03       Impact factor: 4.799

3.  Isolation of a new herpesvirus from human CD4+ T cells.

Authors:  N Frenkel; E C Schirmer; L S Wyatt; G Katsafanas; E Roffman; R M Danovich; C H June
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

Review 4.  Ocular herpes simplex virus type 1: is the cornea a reservoir for viral latency or a fast pit stop?

Authors:  David P Kennedy; Christian Clement; Richard L Arceneaux; Partha S Bhattacharjee; Tashfin S Huq; James M Hill
Journal:  Cornea       Date:  2011-03       Impact factor: 2.651

5.  HSV-1 DNA in tears and saliva of normal adults.

Authors:  Herbert E Kaufman; Ann M Azcuy; Emily D Varnell; Gregory D Sloop; Hilary W Thompson; James M Hill
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-01       Impact factor: 4.799

6.  Herpes simplex virus latency in human cornea.

Authors:  Y Shimomura; Y Mori; Y Inoue; A Kiritooshi; Y Ohashi; R Manabe
Journal:  Jpn J Ophthalmol       Date:  1993       Impact factor: 2.447

7.  Presence of a large amount of herpes simplex virus genome in tear fluid of herpetic stromal keratitis and persistent epithelial defect patients.

Authors:  Masahiko Fukuda; Tatsunori Deai; Shiro Higaki; Kozaburo Hayashi; Yoshikazu Shimomura
Journal:  Semin Ophthalmol       Date:  2008 Jul-Aug       Impact factor: 1.975

8.  Human herpesvirus 6 latently infects early bone marrow progenitors in vivo.

Authors:  M Luppi; P Barozzi; C Morris; A Maiorana; R Garber; G Bonacorsi; A Donelli; R Marasca; A Tabilio; G Torelli
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

9.  Evidence for herpes simplex viral latency in the human cornea.

Authors:  S B Kaye; C Lynas; A Patterson; J M Risk; K McCarthy; C A Hart
Journal:  Br J Ophthalmol       Date:  1991-04       Impact factor: 4.638

10.  Latency-associated transcript (LAT) exon 1 controls herpes simplex virus species-specific phenotypes: reactivation in the guinea pig genital model and neuron subtype-specific latent expression of LAT.

Authors:  Andrea S Bertke; Amita Patel; Yumi Imai; Kathleen Apakupakul; Todd P Margolis; Philip R Krause
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

View more
  6 in total

Review 1.  Pathogenesis of herpes simplex keratitis: The host cell response and ocular surface sequelae to infection and inflammation.

Authors:  Ann-Marie Lobo; Alex M Agelidis; Deepak Shukla
Journal:  Ocul Surf       Date:  2018-10-11       Impact factor: 5.033

Review 2.  Herpes Simplex Virus Establishment, Maintenance, and Reactivation: In Vitro Modeling of Latency.

Authors:  Nikki M Thellman; Steven J Triezenberg
Journal:  Pathogens       Date:  2017-06-23

3.  Evaluation of multiplex real-time polymerase chain reaction for the detection of herpes simplex virus-1 and 2 and varicella-zoster virus in corneal cells from normal subjects and patients with keratitis in India.

Authors:  Sai Jeevana Madhuri Guda; Bhavani Sontam; Bhupesh Bagga; Konduri Ranjith; Savitri Sharma; Joveeta Joseph
Journal:  Indian J Ophthalmol       Date:  2019-07       Impact factor: 1.848

4.  Quantitative analysis of herpes simplex virus-1 transcript in suspected viral keratitis corneal buttons and its clinical significance.

Authors:  Shahzan Anjum; Seema Sen; Rinky Agarwal; Namrata Sharma; Seema Kashyap; Anjana Sharma
Journal:  Indian J Ophthalmol       Date:  2021-04       Impact factor: 1.848

5.  Absence of Herpesvirus DNA in Aqueous Humor from Asymptomatic Subjects.

Authors:  Joanna von Hofsten; Tomas Bergström; Madeleine Zetterberg
Journal:  Clin Ophthalmol       Date:  2022-03-30

Review 6.  Disturbed Yin-Yang balance: stress increases the susceptibility to primary and recurrent infections of herpes simplex virus type 1.

Authors:  Chang Yan; Zhuo Luo; Wen Li; Xue Li; Robert Dallmann; Hiroshi Kurihara; Yi-Fang Li; Rong-Rong He
Journal:  Acta Pharm Sin B       Date:  2019-06-22       Impact factor: 11.413

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.